鏈接：https://www.antibodysystem.com/product/21631.html

名稱(chēng)：InVivoMAb Anti-Mouse CD198/CCR8 Antibody (Iv0255)體內中和抗體，活性抗體

別名：C-C chemokine receptor type 8, C-C CKR-8, CC-CKR-8, CCR-8, CDw198, Ccr8, Cmkbr8, Ter1，CD198/CCR8抗體

貨號：VME85601

宿主：Mouse

適用物種：Mouse

存儲緩沖區：0.01M PBS, pH 7.4.

形式：Liquid

純度：>95%

克?。?/span>Monoclonal

同型：IgG2a, kappa

應用：ELISA, Neutralization

內毒素水平：Please contact with the lab for this information.

UniProt：P56484

用途范圍：僅用于科研

儲存：Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

如果您對CD198/CCR8感興趣可以咨詢(xún)我們相關(guān)產(chǎn)品：

Research Grade Anti-Human CD198/CCR8 (CM369) (DHE85607)

Research Grade Anti-Human CD198/CCR8 (HFB101110) (DHE85604)

Research Grade Anti-Human CD198/CCR8 (SRF114) (DHE85603)

Research Grade Anti-Human CD198/CCR8 (FPA157) (DHE85602)

Research Grade Anti-Human CD198/CCR8 (BMS-986340) (DHE85605)

InVivoMAb Anti-Rat CD198/CCR8 Antibody (Iv0256) (VRE85601)

InVivoMAb Anti-Mouse CD198/CCR8 Antibody (Iv0255) (VME85601)

Research Grade Anti-Human CD198/CCR8 (GS-1811/JTX-1811) (DHE85601)

Anti-Human CD198/CCR8 Antibody (SAA1405) (FHE85620)

Anti-Human CD198/CCR8 Antibody (21360) (FHE85610)

Recombinant Human CD198/CCR8, N-His (YHE85601)

產(chǎn)品購買(mǎi)聯(lián)系方式：027-65279366 /18162686757

郵箱：biolab-reagents@atagenix.com

QQ：2663991332

參考文獻：

CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory. PMID: 35140181

Chemokine Receptor-Targeted Therapies: Special Case for CCR8. PMID: 35158783

Differential expression of CCR8 in tumors versus normal tissue allows specific depletion of tumor-infiltrating T regulatory cells by GS-1811, a novel Fc-optimized anti-CCR8 antibody. PMID: 36352891

S-531011, a Novel Anti-Human CCR8 Antibody, Induces Potent Antitumor Responses through Depletion of Tumor-Infiltrating CCR8-Expressing Regulatory T Cells. PMID: 37420296

Blocking CCL8-CCR8-Mediated Early Allograft Inflammation Improves Kidney Transplant Function. PMID: 35973731

CD4(+)CCR8(+) Tregs in ovarian cancer: a potential effector Tregs for immune regulation. PMID: 37950246

Oxamate enhances the efficacy of CAR-T therapy against glioblastoma via suppressing ectonucleotidases and CCR8 lactylation. PMID: 37770937

The impact of CCR8+ regulatory T cells on cytotoxic T cell function in human lung cancer. PMID: 35354899

TGF-beta-induced CCR8 promoted macrophage transdifferentiation into myofibroblast-like cells. PMID: 35377281

CCR8 as a Therapeutic Novel Target: Omics-Integrated Comprehensive Analysis for Systematically Prioritizing Indications. PMID: 38001911

CCR8 Signaling via CCL1 Regulates Responses of Intestinal IFN-gamma Producing Innate Lymphoid CelIs and Protects From Experimental Colitis. PMID: 33613532

CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancer. PMID: 32367308

Role of chemokines in the crosstalk between tumor and tumor-associated macrophages. PMID: 36173487

The Chemokine Receptor CCR8 Is a Target of Chimeric Antigen T Cells for Treating T Cell Malignancies. PMID: 35693763